Authors:
Zdravkovic, M
Christiansen, T
Eliot, L
Agersoe, H
Thomsen, MS
Falch, JF
Sogaard, B
Ynddal, L
Ilondo, MM
Citation: M. Zdravkovic et al., The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects, GROWTH H I, 11(1), 2001, pp. 41-48
Authors:
Zdravkovic, M
Muller, M
Larsen, S
Degenkolb, J
Pabst, G
Citation: M. Zdravkovic et al., Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets, INT J CL PH, 39(1), 2001, pp. 41-46
Authors:
Agerso, H
Ynddal, L
Sogaard, B
Zdravkovic, M
Citation: H. Agerso et al., Pharmacokinetic and pharmacodynamic modeling of NN703, a growth hormone secretagogue, after a single po dose to human volunteers, J CLIN PHAR, 41(2), 2001, pp. 163-169
Authors:
Zdravkovic, M
Christiansen, T
Grosch, K
Ilondo, MM
Citation: M. Zdravkovic et al., Evaluation of the conformity of human growth hormone concentrations measured with the DPC Immulite (R) and the Nichols (R) Advantage (TM) assays, CLIN CH L M, 38(8), 2000, pp. 799-800
Authors:
Zdravkovic, M
Sogaard, B
Ynddal, L
Christiansen, T
Agerso, H
Thomsen, MS
Falch, JE
Ilondo, MM
Citation: M. Zdravkovic et al., The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers, GROWTH H I, 10(4), 2000, pp. 193-198
Authors:
Zdravkovic, M
Aboagye-Mathiesen, G
Guimond, MJ
Hager, H
Ebbesen, P
Lala, PK
Citation: M. Zdravkovic et al., Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells, PLACENTA, 20(5-6), 1999, pp. 431-440